These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1416860)

  • 1. Antibacterial activity of RU44790, a new N-tetrazolyl monocyclic beta-lactam.
    Chantot JF; Klich M; Teutsch G; Bryskier A; Collette P; Markus A; Seibert G
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1756-63. PubMed ID: 1416860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antibacterial properties of T-5575 and T-5578 novel parenteral 2-carboxypenams.
    Watanabe Y; Minami S; Hayashi T; Araki H; Kitayama R; Ochiai H
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2787-91. PubMed ID: 8593021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antibacterial activity and interactions with beta-lactamases and penicillin-binding proteins of the new monocarbam antibiotic U-78608.
    Zurenko GE; Truesdell SE; Yagi BH; Mourey RJ; Laborde AL
    Antimicrob Agents Chemother; 1990 May; 34(5):884-8. PubMed ID: 2193625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of CP-65,207, a new penem antimicrobial agent, in comparison with those of other agents.
    Gootz T; Retsema J; Girard A; Hamanaka E; Anderson M; Sokolowski S
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1160-6. PubMed ID: 2679370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antibacterial activity of KP-736, a new cephem antibiotic.
    Maejima T; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1991 Jan; 35(1):104-10. PubMed ID: 2014964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
    Utsui Y; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1085-92. PubMed ID: 3310868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SQ 26,180, a novel monobactam. I Taxonomy, fermentation and biological properties.
    Wells JS; Trejo WH; Principe PA; Bush K; Georgopapadakou N; Bonner DP; Sykes RB
    J Antibiot (Tokyo); 1982 Feb; 35(2):184-8. PubMed ID: 6978877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
    Watanabe N; Katsu K; Moriyama M; Kitoh K
    Antimicrob Agents Chemother; 1988 May; 32(5):693-701. PubMed ID: 3134847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.
    Neu HC
    Curr Clin Top Infect Dis; 1987; 8():37-61. PubMed ID: 3077281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of structural properties of beta-lactam antibiotics to antibacterial activity.
    Neu HC
    Am J Med; 1985 Aug; 79(2A):2-13. PubMed ID: 3895915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aztreonam: the first monobactam.
    Sykes RB; Bonner DP
    Am J Med; 1985 Feb; 78(2A):2-10. PubMed ID: 3871589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo activities of DN-9550, a new broad-spectrum cephalosporin.
    Une T; Otani T; Sato M; Ikeuchi T; Osada Y; Ogawa H; Sato K; Mitsuhashi S
    Antimicrob Agents Chemother; 1985 Apr; 27(4):473-8. PubMed ID: 3873898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of CGP 31523A, a broad-spectrum cephalosporin, in comparison with those of other agents.
    Wise R; Cross C; Andrews JM
    Antimicrob Agents Chemother; 1984 Dec; 26(6):876-80. PubMed ID: 6524904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall.
    Fontana R; Altamura M; Arcamone F; Mazzariol A; Morandotti G; Sperning R; Cornaglia G
    J Antimicrob Chemother; 1998 May; 41(5):513-25. PubMed ID: 9630405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
    Yoshida T; Tateda E; Hiramatsu K; Yokota T
    Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of the in vitro spectrum of activity of imipenem.
    Jones RN
    Am J Med; 1985 Jun; 78(6A):22-32. PubMed ID: 3890537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of action of azthreonam.
    Georgopapadakou NH; Smith SA; Sykes RB
    Antimicrob Agents Chemother; 1982 Jun; 21(6):950-6. PubMed ID: 6180685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria.
    Sykes RB; Bonner DP; Bush K; Georgopapadakou NH
    Antimicrob Agents Chemother; 1982 Jan; 21(1):85-92. PubMed ID: 6979307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.
    Tsuchiya K; Kondo M; Kida M; Nakao M; Iwahi T; Nishi T; Noji Y; Takeuchi M; Nozaki Y
    Antimicrob Agents Chemother; 1981 Jan; 19(1):56-65. PubMed ID: 6941742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergism and antagonism in double beta-lactam antibiotic combinations.
    Gutmann L; Williamson R; Kitzis MD; Acar JF
    Am J Med; 1986 May; 80(5C):21-9. PubMed ID: 3487247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.